"At Saint Paul Rheumatology our doctors and staff are empowered to focus on what matters most: improving your quality of life. This approach drives everything we do, including our progressive approach to medication and pursuit of cutting-edge treatments for rheumatoid arthritis and autoimmune diseases."

During the past decade, St. Paul Rheumatology, P.A. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 19 clinical trials were completed, i.e. on average, 95% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Paul Rheumatology, P.A." #1 sponsor was "Bristol-Myers Squibb" with 8 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Amgen" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Paul Rheumatology, P.A." #1 collaborator was "Galapagos NV" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "St. Paul Rheumatology, P.A." are "Rheumatoid Arthritis" (13 trials), "Psoriatic Arthritis" (8 trials), "Arthritis, Psoriatic" (4 trials), "Ankylosing Spondylitis" (1 trials) and "Ankylosing Spondyloarthritis" (1 trials). Many other conditions were trialed in "St. Paul Rheumatology, P.A." in a lesser frequency.

Most popular intervention types in "St. Paul Rheumatology, P.A." are "Drug" (29 trials), "Biological" (8 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Abatacept" (6 trials), "Methotrexate" (4 trials), "Adalimumab" (3 trials) and "Filgotinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Paul Rheumatology, P.A." are 33 trials for "All" genders.

Currently, there are NaN active trials in "St. Paul Rheumatology, P.A.". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in St. Paul Rheumatology, P.A., undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in St. Paul Rheumatology, P.A., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".